1.22BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US03209R1032
CUSIP
03209R103
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
9.25
PEG Ratio
2.77
Book Value
15.76
Dividend Share
-
Dividend Yield
-
Earnings Share
2.76
Wall Street Target Price
32.40
EPS Estimate Current Year
3.12
EPS Estimate Next Year
3.51
EPS Estimate Current Quarter
0.6877
EPS Estimate Next Quarter
0.7234
Most Recent Quarter
-
Revenue TTM
730,659,008
Gross Profit TTM
369,006,016
EBITDA
248,295,008
Profit Margin
19.38%
Return On Assets TTM
7.60%
Return On Equity TTM
19.90%
Revenue Per Share TTM
15.132
Qtly Revenue Growth YOY
-0.80%
Diluted Eps TTM
2.76
Qtly Earnings Growth YOY
-37.00%
Trailing PE
9.25
Forward PE
0
Price Sales TTM
1.6464
Price Book MRQ
1.6012
Enterprise Value Revenue
2
Enterprise Value EBITDA
6
143.16
12.72%17.70
2.64%170.16
0.92%53.51
0.07%15.00
0.07%17.80
0.00%27.60
0.00%129.70
-2.30%5.63
-0.18%26.30
-0.08%